Zacks Research Lifts Earnings Estimates for Cardinal Health

Cardinal Health, Inc. (NYSE:CAH) – Equities research analysts at Zacks Research lifted their FY2025 earnings estimates for shares of Cardinal Health in a research report issued to clients and investors on Thursday, February 20th. Zacks Research analyst R. Department now forecasts that the company will earn $7.88 per share for the year, up from their previous forecast of $7.75. The consensus estimate for Cardinal Health’s current full-year earnings is $7.95 per share. Zacks Research also issued estimates for Cardinal Health’s Q1 2026 earnings at $2.01 EPS, Q3 2026 earnings at $2.54 EPS, FY2026 earnings at $8.85 EPS, Q1 2027 earnings at $2.15 EPS, Q2 2027 earnings at $2.20 EPS and FY2027 earnings at $9.36 EPS.

A number of other equities research analysts have also recently commented on the stock. Argus set a $148.00 target price on shares of Cardinal Health in a research report on Tuesday, February 4th. Evercore ISI raised shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 target price on the stock in a research note on Tuesday, January 7th. Citigroup boosted their target price on Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a report on Friday, January 10th. StockNews.com downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd. Finally, Mizuho started coverage on Cardinal Health in a research note on Wednesday, December 4th. They set an “outperform” rating and a $139.00 price objective on the stock. Four analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $138.40.

Cardinal Health Stock Performance

Shares of CAH opened at $127.90 on Monday. The stock has a 50 day moving average price of $124.08 and a 200 day moving average price of $117.72. The stock has a market capitalization of $30.90 billion, a price-to-earnings ratio of 23.86, a PEG ratio of 1.49 and a beta of 0.63. Cardinal Health has a one year low of $93.17 and a one year high of $132.84.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a yield of 1.58%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health’s payout ratio is 37.69%.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the company. State Street Corp lifted its stake in Cardinal Health by 4.6% during the 3rd quarter. State Street Corp now owns 14,177,641 shares of the company’s stock worth $1,566,913,000 after acquiring an additional 627,253 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Cardinal Health by 1.9% in the fourth quarter. Geode Capital Management LLC now owns 5,859,132 shares of the company’s stock valued at $691,145,000 after purchasing an additional 109,273 shares during the period. Pacer Advisors Inc. grew its holdings in shares of Cardinal Health by 4.7% in the third quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company’s stock valued at $474,203,000 after purchasing an additional 191,568 shares in the last quarter. Invesco Ltd. increased its stake in Cardinal Health by 4.6% during the 4th quarter. Invesco Ltd. now owns 3,182,514 shares of the company’s stock worth $376,396,000 after buying an additional 140,368 shares during the period. Finally, Marshall Wace LLP lifted its holdings in Cardinal Health by 154.6% during the 4th quarter. Marshall Wace LLP now owns 3,151,736 shares of the company’s stock worth $372,756,000 after buying an additional 1,913,892 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.